Allan Silber
Chairman at POINT Biopharma Corp.
Net worth: 5 M $ as of 2024-03-30
Profile
Allan C.
Silber was the founder and had founded Street Capital Group, Inc. in 1979, where he held the title of Chairman from 2012 to 2019.
He currently holds the position of Executive Chairman at POINT Biopharma Corp., Chairman at Verity Pharmaceuticals, Inc., Executive Chairman at POINT Biopharma, Inc. (United States), Director at Anglian Holdings LLC, and Governor at Jewish National Fund of Canada.
In his former positions, Mr. Silber served as Chairman & President at C2 Global Technologies, Inc. from 2001 to 2011, Chairman at Terra Firma Capital Corp.
from 2007 to 2013, Chairman at Knight's Bridge Capital Partners, Inc., Co-Chairman at United Jewish Appeal, Chairman at Heritage Global, Inc. from 2001 to 2021, Chairman at RFA Bank of Canada, Executive Chairman at POINT Biopharma Global, Inc. from 2021 to 2023, and Director at Captiva Verde Industries Ltd.
Mr. Silber obtained his undergraduate degree from the University of Toronto.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HERITAGE GLOBAL INC.
4.87% | 2023-03-09 | 1,810,913 ( 4.87% ) | 5 M $ | 2024-03-30 |
Allan Silber active positions
| Companies | Position | Start |
|---|---|---|
| Jewish National Fund of Canada | Corporate Officer/Principal | 2014-06-16 |
Verity Pharmaceuticals, Inc.
 Verity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verity Pharmaceuticals, Inc. operates as a pharmaceutical company. It provides therapeutically relevant agents to the Canadian healthcare community. The company was founded in 2016 and is headquartered in Mississauga, ON. | Chairman | 2017-12-31 |
POINT Biopharma Corp.
 POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The private company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | Chairman | - |
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Chairman | 2019-12-31 |
| Anglian Holdings LLC | Director/Board Member | - |
Former positions of Allan Silber
| Companies | Position | End |
|---|---|---|
| POIT BIOP | Chairman | 2023-12-26 |
| HERITAGE GLOBAL INC. | Chairman | 2021-03-03 |
| STREET CAPITAL GROUP INC. | Chief Executive Officer | 2015-05-31 |
RFA Bank of Canada
 RFA Bank of Canada Finance/Rental/LeasingFinance RFA Bank of Canada offers residential mortgage solutions. The private company is based in Toronto, Canada. Duncan Hannay has been the CEO of the Canadian company since 2017. | Chairman | 2019-01-02 |
| ░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Training of Allan Silber
| University of Toronto | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| TERRA FIRMA CAPITAL CORPORATION | Finance |
| POIT BIOP | Health Technology |
| Private companies | 12 |
|---|---|
Street Capital Group, Inc.
 Street Capital Group, Inc. Finance/Rental/LeasingFinance Street Capital Group, Inc. through its subsidiary Street Capital Bank of Canada, engages in the provision of deposit and residential mortgage solutions. Its services include deposit and residential mortgage, consumer lending, and related services. The company was founded by Allan C. Silber on August 2, 1979 and is headquartered in Toronto, Canada. | Finance |
C2 Global Technologies, Inc.
 C2 Global Technologies, Inc. Specialty TelecommunicationsCommunications C2 Global Technologies, Inc. offers a pioneer in developing Voice over Internet Protocol technology services. Its concurrent network development offers a blend of innovative communications services that utilized the inherent cost advantages of its nationwide IP-based network. It also develops an open API tool kit to allow developers to create their own solutions deliverable via a VoIP network at a fraction of the cost of traditional development. The company was founded in 1983 and is headquartered in Toronto, ON. | Communications |
Captiva Verde Industries Ltd.
 Captiva Verde Industries Ltd. Beverages: Non-AlcoholicConsumer Non-Durables Captiva Verde Industries Ltd. engages in the provision of organic greens and other organic products. Its product includes spinach, kale, arugula, chard, mustard, lettuce. The company was founded on October 7, 1993 and is headquartered in La Quinta, CA. | Consumer Non-Durables |
Knight's Bridge Capital Partners, Inc.
 Knight's Bridge Capital Partners, Inc. Investment ManagersFinance Knight's Bridge Capital Partners, Inc (Knight's Bridge Capital), a subsidiary of Counsel Corp. (Toronto: CXS.TO), is a family office and private equity firm headquartered in Toronto, Canada with an additional offices in Phoenix, Arizona founded by Kenneth J Finkelstein in November, 2006. | Finance |
| United Jewish Appeal | |
| Heritage Global, Inc. | |
| Jewish National Fund of Canada | |
RFA Bank of Canada
RFA Bank of Canada Finance/Rental/LeasingFinance RFA Bank of Canada offers residential mortgage solutions. The private company is based in Toronto, Canada. Duncan Hannay has been the CEO of the Canadian company since 2017. | Finance |
POINT Biopharma Corp.
POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The private company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | Commercial Services |
Verity Pharmaceuticals, Inc.
Verity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verity Pharmaceuticals, Inc. operates as a pharmaceutical company. It provides therapeutically relevant agents to the Canadian healthcare community. The company was founded in 2016 and is headquartered in Mississauga, ON. | Health Technology |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
| Anglian Holdings LLC |
- Stock Market
- Insiders
- Allan Silber
